About this Research Topic
With the advancement of genetic research, it is now possible to predict the onset of triplet repeat disease in at-risk individuals with a high frequency through genetic testing (pre-onset testing). As such, preventing or eradicating the onset of these intractable diseases by providing early intervention to patients.
Thus, topic editors will welcome any types of manuscripts supported by the Journal – comprised of research article, brief research article, review, and mini-review – about, but not limited to the following themes:
• New treatment for Huntington's disease
• New treatment for spinocerebellar degeneration
• New treatment for myotonic dystrophy
• Treatment based on triplet repeat disease
• Treatment with antibody drugs and modifiers for nerve repeat disease
Keywords: Memantine, naphthyridine-azaquinolone (NA), Arginine
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.